1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Dhanvantri Jeevan Rekha Limited

Dhanvantri Jeevan Rekha Limited

BBSE:ZDHJERK
23.56
INR
-1.24
(-5.00%)
1.23EPS
22.54P/E
113.85MMarket Cap
Dhanvantri Jeevan Rekha Limited
BSE:ZDHJERK
(Bombay Stock Exchange)

Recent

price

23.56

P/E

ratio

22.54

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
9.91
11.14
14.04
17.72
19.46
22.58
27.31
33.77
39.57
44.1
23.87
40.92
43.15
49.93
55.27
63.09
68.15
Revenue per Share
0.59
1.03
2.05
1.27
2.52
2.33
1.33
1.78
0.11
-0.64
-3.47
1.2
-0.53
0.4
1.23
0.95
1.23
Basic EPS, GAAP
- -
-1.63
1.97
2.25
-1.86
-0.64
-5.05
-1.04
2.01
3.34
-1.05
2.18
-2.52
6.27
-2.57
2.41
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
11.88
12.91
14.97
16.24
20.61
22.94
24.27
26.05
26.16
25.52
22.05
23.24
22.71
23.12
24.72
25.66
- -
Book Value per Share
11.88
12.91
14.97
16.24
20.61
22.94
24.27
26.05
26.16
25.52
22.05
23.24
22.71
23.12
24.72
25.66
- -
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
41
46
58
73
80
93
112
138
168
182
98
168
177
205
227
259
282
Sales/Revenue/Turnover
12.07
9.85
15.31
9.52
14.67
13.01
11.22
5.44
0.63
-2.39
-18.29
2.84
-2.12
-0.16
0.8
0.6
0.82
Operating Margin (%)
5
5
6
7
4
3
4
11
11
11
10
10
10
9
6
7
7
Depreciation Expense
2
4
8
5
10
10
5
7
- -
-3
-14
5
-2
2
5
4
5
Net Income, GAAP
50
24.73
17.02
37.88
29.93
32.41
43.38
- -
59.92
- -
- -
27.19
- -
35.32
8.95
2.31
- -
Effective Tax Rate (%)
5.91
9.25
14.61
7.16
12.93
10.3
4.87
5.27
0.28
-1.45
-14.55
2.92
-1.23
0.81
2.23
1.51
1.81
Profit Margin (%)
10
-2
9
18
18
26
-1
1
-7
-3
-5
6
7
17
15
9
- -
Working Capital
1
2
- -
- -
- -
9
19
19
1
1
1
- -
- -
- -
- -
- -
- -
LT Debt
49
53
61
67
84
94
99
107
107
105
90
95
93
95
101
105
- -
Total Equity
- -
7.76
13.81
8.6
14.06
10.13
4.89
- -
0.36
- -
- -
3.72
- -
-0.22
1.42
0.75
- -
Return on Invested Capital (%)
- -
7.91
14.12
8.12
13.97
10.66
5.79
- -
0.67
- -
- -
5.28
- -
1.76
5.16
3.88
- -
Return on Capital (%)
- -
8.31
14.71
8.13
13.65
10.68
5.64
7.06
0.44
-2.5
-14.6
5.28
-2.3
1.76
5.16
3.79
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
104
103
114

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
64
- -
Cash, Cash Equivalents & STI
- -
37
- -
Accounts Receivable, Net
- -
26
- -
Inventories
- -
1
- -
Total Current Liabilities
- -
55
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.32%
3.13%
3.8%
Free Cash Flow
-96.41%
-241.57%
-193.74%
Net Income, GAAP
-60.01%
-54.29%
-22.8%
Sales/Revenue/Turnover
14.55%
23.49%
14.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
57
54
57
58
227
2026
55
58
73
72
259
2027
78
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.39
0.4
0.36
0.07
1.23
2026
0.15
-0.34
0.41
0.72
0.95
2027
0.44
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Dhanvantri Jeevan Rekha Limited operates a NABH-accredited multi-specialty hospital, Dhanvantri Hospital, providing diagnostic, therapeutic, and patient care services in Meerut, India. The company offers a comprehensive range of super specialty services including cardiology with cath lab facilities for angiography, angioplasty, pacemaker implantation, and valvuloplasty; gastroenterology; neurology; urology; nephrology; internal medicine; pulmonology; intensive coronary care and general intensive care units; oral and maxillofacial surgery; pathology; rehabilitation; oncology; and other diagnostic investigations. It serves patients across all demographics in the western Uttar Pradesh region through specialized therapy, medical treatment, surgery, and 24-hour emergency care with state-of-the-art equipment. Founded in 1993 and headquartered at 1, Saket, Meerut, Uttar Pradesh, the company maintains an almost debt-free balance sheet and focuses on continuous facility upgrades to world-class standards. In recent developments, Dhanvantri Jeevan Rekha reported net profit growth to Rs 0.51 crore for the fiscal year ended March 2025, up from Rs 0.17 crore the prior year, alongside revenue increase to Rs 22.65 crore; it approved unaudited Q1 fiscal 2026 results in August 2025 and confirmed regulatory compliance for share dematerialization in July 2025.